Artelo Biosciences Inc. Common Stock (ARTL)

About ARTL

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

artelobio.com/

Fundamentals

Market cap

$2.62M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-38.91

Dividend yield

—

Beta

-0.16

Avg. volume

—

Artelo Biosciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ARTL

  Artelo Biosciences Inc. Common Stock

  $0.6619

  ▲ 0.14%
  Market cap $2.62MP/E —
  $0.52$28.14
• CDT

  CDT Equity Inc. Common Stock

  $1.69

  ▼ 10.37%
  Market cap $2.54MP/E —
  $1.62$2,928
• OGEN

  Oragenics Inc. Common Stock

  $0.5296

  ▼ 0.08%
  Market cap $2.45MP/E 0.56
  $0.4801$1.45
• SBFM

  Sunshine Biopharma Inc. Common Stock

  $1.16

  ▼ 8.66%
  Market cap $2.97MP/E —
  $1.01$24.3
• ONCO

  Onconetix Inc. Common Stock

  $0.6121

  ▼ 3.15%
  Market cap $3.34MP/E 0.00
  $0.6207$209.5
• XRTX

  XORTX Therapeutics Inc. Common Shares

  $2.34

  ▼ 4.18%
  Market cap $3.51MP/E —
  $2.42$9.85
• MTNB

  Matinas Biopharma Holdings Inc. Common Stock

  $0.1966

  ▼ 1.70%
  Market cap $1.72MP/E —
  $0.178$2.14

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY
  Benzinga · 8/13/2026
• Artelo Biosciences Says First Patient Dosed In DREAM Study Evaluating Effects Of ART27.13 In Patients With Glaucoma Or Ocular Hypertension; Initial DREAM Study Results Anticipated In Q4
  Benzinga · 8/10/2026

• Blayney Douglas · July 17, 2026 · Grant

  136
• Reyes Gregory · July 17, 2026 · Grant

  136
• Kelly Steven · July 17, 2026 · Grant

  136
• FAVORITO TAMARA A · July 17, 2026 · Grant

  136
• Connie Matsui · July 17, 2026 · Grant

  136
• EMANUELE ROBERT MARTIN · July 17, 2026 · Grant

  136

Institutional Ownership

March 31, 2026

Total shares held

42.5K

Total value held

$321.9K

Institutional holders

9